Since these cytokines, as discussed above, can regulate ABCB1 expression, an increase in pro-inflammatory cytokines in the brains of AD patients could reduce ABCB1 expression or function, contributing to the pathogenesis or progression of AD. The gene discussed is ABCB1; the disease is Alzheimer disease.